arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

RadNet, Inc.

RDNT
$78.08 ▼ -2.22 (-2.76%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
17 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
38
Health
Weak
Neutral
auto_awesome

Analytical Summary

RadNet, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $5.9B
Dividend Yield —
Revenue Growth 11.5% ↘
Op. Margin 3.0% ↘
ROIC 1.5% ↘
FCF / Share $3.97 ↗
Trailing P/E —
Price / Book 5.3x
FCF Yield 5.1%
Debt / Equity 1.00
info Valuation on last close. End-of-day price, Nov 5, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.04B
↑ +11.5% —
Net Income Profit after all expenses
$-18.65M
↓ -767.8% —
Operating Margin Operating profit as % of sales
3.0%
↓ -46.9% 37th
FCF / Share Free cash flow per share
$3.97
↑ +24.6% —
Long-Term Debt Long-term obligations
$1.09B
↑ +7.2% —

Health Breakdown

Profitability →
46
Returns
42
Financial Health ↓
41
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 67 quarters